Product Code: 02-BRCA-ESR1-26
From £299.00 Early Bird
Early Bird Deadline: 31/01/2026
Deadline to order: 28/02/2026
ESR1 and PIK3CA testing in cfDNA (plasma) for metastatic breast cancer. This EQA is sponsored.
The scope of this EQA includes testing for actionable and resistant variants in the ESR1 and PIK3CA genes in cfDNA plasma in metastatic breast cancer in the context of targeted therapies, such as SERDs and PI3K inhibitors.
NGS, Panel testing, PCR based
English, French, German, Italian, Spanish
Plasma (cfDNA)
No
September 2026
September - November 2026
May - June 2027
You can complete purchase on our secure partner site.
The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy.
Three mock clinical cases; 2 with matching samples and 1 virtual case will be provided will be provided, 3ml artificial / synthetic plasma is provided per case. Complete information will be available in scheme instructions.
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
Participants are expected to test the samples according to their routine strategy, to return a clinical report and to complete the data collection form.
This EQA is supported by an educational grant from AstraZeneca, fees are subsidised so there is a reduced cost for participants. EMQN acknowledge and thank AstraZeneca for this support.
Restricted to 100 participants, please register early to avoid disappointment. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.
